171 related articles for article (PubMed ID: 23244432)
1. Modulation of monoaminergic transporters by choline-containing phospholipids in rat brain.
Tayebati SK; Tomassoni D; Nwankwo IE; Di Stefano A; Sozio P; Cerasa LS; Amenta F
CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):94-103. PubMed ID: 23244432
[TBL] [Abstract][Full Text] [Related]
2. Effect of choline-containing phospholipids on brain cholinergic transporters in the rat.
Tayebati SK; Tomassoni D; Di Stefano A; Sozio P; Cerasa LS; Amenta F
J Neurol Sci; 2011 Mar; 302(1-2):49-57. PubMed ID: 21195433
[TBL] [Abstract][Full Text] [Related]
3. Effects of cholinergic enhancing drugs on cholinergic transporters in the brain and peripheral blood lymphocytes of spontaneously hypertensive rats.
Tomassoni D; Catalani A; Cinque C; Di Tullio MA; Tayebati SK; Cadoni A; Nwankwo IE; Traini E; Amenta F
Curr Alzheimer Res; 2012 Jan; 9(1):120-7. PubMed ID: 22191561
[TBL] [Abstract][Full Text] [Related]
4. Choline alphoscerate (alpha-glyceryl-phosphoryl-choline) an old choline- containing phospholipid with a still interesting profile as cognition enhancing agent.
Traini E; Bramanti V; Amenta F
Curr Alzheimer Res; 2013 Dec; 10(10):1070-9. PubMed ID: 24156263
[TBL] [Abstract][Full Text] [Related]
5. Oral cytidine 5'-diphosphate choline administration to rats increases brain phospholipid levels.
Agut J; Lopez G-Coviella I; Ortiz JA; Wurtman RJ
Ann N Y Acad Sci; 1993 Sep; 695():318-20. PubMed ID: 8239304
[TBL] [Abstract][Full Text] [Related]
6. Cerebrovascular and blood-brain barrier morphology in spontaneously hypertensive rats: effect of treatment with choline alphoscerate.
Tayebati SK; Amenta F; Tomassoni D
CNS Neurol Disord Drug Targets; 2015; 14(3):421-9. PubMed ID: 25714975
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of free plasma choline levels following intramuscular administration of L-alpha-glycerylphosphorylcholine and citicoline in normal volunteers.
Gatti G; Barzaghi N; Acuto G; Abbiati G; Fossati T; Perucca E
Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):331-5. PubMed ID: 1428296
[TBL] [Abstract][Full Text] [Related]
8. Choline-containing phospholipids: relevance to brain functional pathways.
Tayebati SK; Amenta F
Clin Chem Lab Med; 2013 Mar; 51(3):513-21. PubMed ID: 23314552
[TBL] [Abstract][Full Text] [Related]
9. Evidence that 5'-cytidinediphosphocholine can affect brain phospholipid composition by increasing choline and cytidine plasma levels.
López-Coviella I; Agut J; Savci V; Ortiz JA; Wurtman RJ
J Neurochem; 1995 Aug; 65(2):889-94. PubMed ID: 7616250
[TBL] [Abstract][Full Text] [Related]
10. The effect of cytidine-diphosphate choline (CDP-choline) on brain lipid changes during aging.
De Medio GE; Trovarelli G; Piccinin GL; Porcellati G
J Neurosci Res; 1984; 11(1):49-58. PubMed ID: 6708133
[TBL] [Abstract][Full Text] [Related]
11. CDP-choline: pharmacological and clinical review.
Secades JJ; Frontera G
Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
[TBL] [Abstract][Full Text] [Related]
12. Choline and Choline alphoscerate Do Not Modulate Inflammatory Processes in the Rat Brain.
Tayebati SK; Martinelli I; Moruzzi M; Amenta F; Tomassoni D
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28961195
[TBL] [Abstract][Full Text] [Related]
13. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
Parnetti L; Mignini F; Tomassoni D; Traini E; Amenta F
J Neurol Sci; 2007 Jun; 257(1-2):264-9. PubMed ID: 17331541
[TBL] [Abstract][Full Text] [Related]
14. Interaction of CDP-choline with synaptosomal transport of biogenic amines and their precursors in vitro and in vivo in the rat corpus striatum.
Martinet M; Fonlupt P; Pacheco H
Experientia; 1978 Sep; 34(9):1197-9. PubMed ID: 31297
[TBL] [Abstract][Full Text] [Related]
15. Effect of choline-containing phospholipids on transglutaminase activity in primary astroglial cell cultures.
Bramanti V; Bronzi D; Tomassoni D; Li Volti G; Cannavò G; Raciti G; Napoli M; Vanella A; Campisi A; Ientile R; Avola R
Clin Exp Hypertens; 2008 Nov; 30(8):798-807. PubMed ID: 19021029
[TBL] [Abstract][Full Text] [Related]
16. Effects of CDP-choline administration on receptor-stimulated inositol phospholipid hydrolysis in brain slices and neuronal cultures.
Canonico PL; Nicoletti F; Sortino MA; Aleppo G; Scapagnini U
Funct Neurol; 1992; 7(4):275-81. PubMed ID: 1330841
[TBL] [Abstract][Full Text] [Related]
17. Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications.
Tayebati SK; Marucci G; Santinelli C; Buccioni M; Amenta F
Curr Med Chem; 2015; 22(38):4328-40. PubMed ID: 26511472
[TBL] [Abstract][Full Text] [Related]
18. Effect of CDP-choline on the biosynthesis of phospholipids in brain regions during hypoxic treatment.
Alberghina M; Viola M; Serra I; Mistretta A; Giuffrida AM
J Neurosci Res; 1981; 6(3):421-33. PubMed ID: 7299849
[TBL] [Abstract][Full Text] [Related]
19. Cytidine-5-diphosphocholine reduces microvascular permeability during experimental endotoxemia.
Schmidt K; Hernekamp JF; Doerr M; Zivkovic AR; Brenner T; Walther A; Weigand MA; Hofer S
BMC Anesthesiol; 2015 Aug; 15():114. PubMed ID: 26232247
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal administration of CDP-choline or a combination of cytidine plus choline improves nerve regeneration and functional recovery in a rat model of sciatic nerve injury.
Caner B; Kafa MI; Bekar A; Kurt MA; Karli N; Cansev M; Ulus IH
Neurol Res; 2012 Apr; 34(3):238-45. PubMed ID: 22449436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
